148 studies found for:    Open Studies | "Thrombocytopenia"
Show Display Options
Rank Status Study
21 Recruiting An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Dexamethasone
22 Unknown  The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention:
23 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
24 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platlet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
25 Not yet recruiting Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Romiplostin
26 Unknown  Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Autoimmune Thrombocytopenia;   Chronic Lymphocytic Leukemia;   Non Hodgkin's Lymphoma
Intervention: Drug: Eltrombopag Olamine
27 Unknown  Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
Condition: Heparin-Induced Thrombocytopenia
Interventions: Other: Scoring 4Ts and Chong scale;   Other: Blood draw
28 Recruiting A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Cyclosporin A;   Drug: rhTPO
29 Recruiting Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Rivaroxaban
30 Recruiting TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.
Conditions: Adult Patients;   Immune Primary Thrombocytopenia;   Splenectomy;   TPO-mimetics
Intervention:
31 Recruiting Study of Romiplostim Versus Observation for Chemotherapy Induced Thrombocytopenia
Condition: Isolated Chemotherapy-induced Thrombocytopenia
Interventions: Biological: romiplostim,;   Other: Control cohort
32 Recruiting A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura
Condition: Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Intervention: Biological: Romiplostim
33 Unknown  Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Conditions: Wiskott-Aldrich Syndrome;   Thrombocytopenia;   Bleeding
Interventions: Drug: Promacta (eltrombopag);   Drug: Eltrombopag/promacta
34 Recruiting rhTPO in Critical Patients With Thrombocytopenia
Conditions: Sepsis;   Thrombocytopenia
Interventions: Drug: TPO;   Drug: control
35 Recruiting Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Conditions: Myelodysplastic Syndrome (MDS);   Thrombocytopenia
Intervention: Drug: Eltrombopag
36 Recruiting Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Alloimmune Platelet Refractoriness
Intervention: Drug: Eculizumab
37 Unknown  Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)
Condition: Thrombocytopenia
Intervention: Other: Steroid refractory ITP
38 Not yet recruiting Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
Conditions: Chronic Liver Disease;   Thrombocytopenia
Interventions: Drug: Lusutrombopag;   Drug: Placebo
39 Unknown  Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Antox tablets(Mepaco);   Other: drug therapy for ITP
40 Recruiting Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia
Condition: Severe Thrombocytopenia
Intervention: Drug: oprelvekin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years